Clinical Trials Logo

HEAVY TOBACCO SMOKERS clinical trials

View clinical trials related to HEAVY TOBACCO SMOKERS.

Filter by:
  • None
  • Page 1

NCT ID: NCT01284660 Completed - Clinical trials for HEAVY TOBACCO SMOKERS

Docosahexaenoic Acid (DHA) Effects on Cognitive Function, Craving and Psychosocial Factors in Heavy Cigarette Smokers

Start date: November 2011
Phase: N/A
Study type: Interventional

The purpose of this study is to assess effects of Docosahexaenoic Acid (DHA) as an add-on novel supplement on quality of life, cognitive function, craving and psychosocial factors in heavy cigarette smokers. In humans, no previous randomized, double blind controlled study has been conducted to evaluate these effects. The aim of the study is to 1. Test Docosahexaenoic Acid (DHA) beneficial effects on objective clinical indicators of cognitive function (choice reaction time, decision making, impulsivity, facial recognition) in smokers 2. Improvement of quality of life, cigarette craving, psychosocial factors and self-perceptions in smokers treated with DHA supplement